发明名称 Orally administered corticosteroid compositions
摘要 The present invention is directed to orally administered corticosteroid compositions. The present invention also provides a method for treating a condition associated with inflammation of the gastrointestinal tract in an individual. The method comprises administering to an individual in need thereof a pharmaceutical composition of the present invention.
申请公布号 US9387167(B2) 申请公布日期 2016.07.12
申请号 US201414311732 申请日期 2014.06.23
申请人 ADARE PHARMACEUTICALS, INC. 发明人 Perrett Stephen;Cohen Fredric Jay;Venkatesh Gopi
分类号 A61K9/00;A61K31/56;A61K31/569;A61K45/06;A61K9/06 主分类号 A61K9/00
代理机构 Cooley LLP 代理人 Cooley LLP
主权项 1. An oral, substantially non-aqueous liquid pharmaceutical composition comprising a corticosteroid, a pharmaceutically acceptable non-aqueous liquid, and a phase change agent dissolved or suspended in the non-aqueous liquid, wherein after oral administration to a patient, said composition undergoes a change in physical properties of the composition upon contact with the upper gastrointestinal tract of said patient, whereby contact of the corticosteroid with the upper gastrointestinal tract of the patient is enhanced and/or prolonged.
地址 Lawrenceville NJ US